Results 11 to 20 of about 40,327 (214)

Risk factors for hospital infections caused by carbapanem-resistant Acinetobacter baumannii

open access: yesJournal of Infection in Developing Countries, 2016
Introduction: Acinetobacter baumannii is one of major causative agents of severe, life-threatening hospital infections (HIs), especially in intensive care units (ICUs).
Zorana M Djordjevic   +5 more
doaj   +1 more source

Discrimination between Carbapenem-Resistant and Carbapenem-Sensitive Klebsiella pneumoniae Strains through Computational Analysis of Surface-Enhanced Raman Spectra: a Pilot Study

open access: yesMicrobiology Spectrum, 2022
In clinical settings, rapid and accurate diagnosis of antibiotic resistance is essential for the efficient treatment of bacterial infections. Conventional methods for antibiotic resistance testing are time consuming, while molecular methods such as PCR ...
Wei Liu   +9 more
doaj   +1 more source

Emergence of VIM-6 metallo-beta-lactamase-producing Alcaligenes faecalis clinical isolates in a hospital in India

open access: yesJournal of Infection in Developing Countries, 2013
This item has no abstract. Use the links below to access the full text.
Atul Khajuria   +3 more
doaj   +1 more source

Parenteral carbapenems [PDF]

open access: yesClinical Microbiology and Infection, 2008
Among the many different structurally distinct classes of beta-lactams, the carbapenem class is regarded as that which is most potent and which has the widest spectrum of antimicrobial activity. Rapidly bactericidal, and demonstrating time-dependent killing, carbapenemes have a spectrum of antimicrobial activity that includes Gram-positive and Gram ...
openaire   +2 more sources

Carbapenem resistance in Canada [PDF]

open access: yesCanadian Medical Association Journal, 2009
For more than 2 decades, carbapenems have been considered the pharmacotherapy of last resort for managing multidrug-resistant infections caused by Enterobacteriaceae bacteria (e.g., Escherichia coli and Salmonella ).
Baldwin, Toye   +4 more
openaire   +2 more sources

Effect of Differences in the CLSI and EUCAST Criteria on the Interpretation of Enterobacteriaceae Sensitivity to Carbapenems

open access: yesАнтибиотики и Химиотерапия, 2021
Relevance: The two systems for determining the susceptibility of bacteria to antimicrobial drugs, CLSI and EUCAST, are recommended for use in the global system of epidemiological surveillance of antimicrobial resistance of the World Health Organization ...
L. A. Kornoukhova   +3 more
doaj   +1 more source

Biapenem: Clinical and Microbiological Characteristics and the Place of The New Carbapenem In The Treatment of Severe Infections In The Hospital. Clinical Pharmacologists' Point of View

open access: yesАнтибиотики и Химиотерапия, 2022
A new carbapenem antibiotic — biapenem — previously used only in Japan and Southeast Asia, was registered in Russia in 2021. The article analyzes the antimicrobial, pharmacokinetic, and clinical characteristics of biapenem in detail, provides ...
S. V. YAKOVLEV, M. P. SUVOROVA
doaj   +1 more source

The Impact of Acinetobacter baumannii Infections in COVID-19 Patients Admitted in Hospital Intensive Care Units

open access: yesBiology and Life Sciences Forum, 2023
Since the end of 2019, the Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally, affecting people worldwide.
Corneliu Ovidiu Vrancianu   +6 more
doaj   +1 more source

THE CORRESPONDENCE OF THE CARBAPENEMASE GENOTYPE AND PHENOTYPIC ANTIMICROBIAL PROFILES OF PSEUDOMONAS AERUGINOSA

open access: yesПроблеми екології та медицини, 2023
The aim of the study was to determine the correspondence between the carbapenemase genotype and the phenotypic antimicrobial profiles of P. aeruginosa. Materials and methods. The study included 51 clinical isolates of P.
N. Bahniuk   +6 more
doaj   +1 more source

Carbapenems and febrile neutropenia [PDF]

open access: yesClinical Microbiology and Infection, 2017
International ...
Alfandari, S.   +2 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy